product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Notch3 Antibody
catalog :
2889
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot, immunoprecipitation, flow cytometry, chromatin immunoprecipitation
citations: 4
Published Application/Species/Sample/DilutionReference
  • western blot; human; fig 2
  • western blot; mouse; fig 3
Franciosa G, Diluvio G, Gaudio F, Giuli M, Palermo R, Grazioli P, et al. Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression. Oncogene. 2016;35:4741-51 pubmed publisher
  • flow cytometry; human
Bhat V, Sun Y, Weger S, Raouf A. Notch-Induced Expression of FZD7 Requires Noncanonical NOTCH3 Signaling in Human Breast Epithelial Cells. Stem Cells Dev. 2016;25:522-9 pubmed publisher
  • chromatin immunoprecipitation; mouse
  • western blot; mouse
Kumar V, Palermo R, Talora C, Campese A, Checquolo S, Bellavia D, et al. Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. Leukemia. 2014;28:2324-35 pubmed publisher
  • western blot; human
Singh A, Zapata M, Choi Y, Yoon S. GSI promotes vincristine-induced apoptosis by enhancing multi-polar spindle formation. Cell Cycle. 2014;13:157-66 pubmed publisher
product information
SKU :
2889S
Product-Name :
Notch3 Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Immunoprecipitation
Product-Category :
Developmental Biology
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
90, 270
Host :
Rabbit
Target :
Notch3
Primary-Protein :
NOTCH3
Alt-Names :
CADASIL,CASIL,NOTC3,NOTCH3,Neurogenic locus notch homolog protein 3,Notch 3,Notch 3 extracellular truncation,Notch 3 intracellular domain,Notch homolog 3 (Drosophila)
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.